Alternatives to Ultragenyx
Ultragenyx is a Biotech tool: biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases. Here are the 50 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Ultragenyx
Emendo BiotherapeuticsNot ratedDeveloping genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Travere TherapeuticsNot ratedA biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
Lexeo TherapeuticsNot ratedClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Caris Life SciencesNot ratedCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Guardant HealthNot ratedGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
CellcolabsNot ratedAI-powered platform for personalized cell therapy development and manufacturing.
Tenaya TherapeuticsNot ratedBiotechnology company developing gene therapies and regenerative medicine for heart disease.
Avidity BiosciencesNot ratedClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
SyantraNot ratedA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Orchard TherapeuticsNot ratedGene therapy company developing treatments for rare inherited diseases.
Bluebird BioNot ratedGene therapy company developing transformative treatments for severe genetic diseases.
MacroGenicsNot ratedBiopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.
iSpecimen .Not ratedGlobal marketplace connecting researchers with human biospecimens for life science research.
Editas MedicineNot ratedA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
AbCelleraNot ratedAI-powered platform for antibody discovery and development to create new medicines.
Intellia TherapeuticsNot ratedA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Nona BiosciencesNot ratedBiotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.
Showing the next 20 closest matches. See the rest on the Ultragenyx profile.
Sponsored rows are paid and labelled. Advertise on this page

